Peripheral neuropathies under Immune Checkpoint Inhibitors: A pharmacovigilance study

被引：0
|
作者：
Ewig, E. [1 ]
Fournier, D. [1 ]
Palassin, P. [2 ]
Cholle, C. [3 ]
Bihan, B. [1 ]
Lebrun-Vignes, B. [1 ]
机构：
[1] GH Sorbonne Univ, Dept Pharmacol, Ctr Reg Pharmacovigilance Pitie St Antoine, AP HP, Paris, France
[2] CHU Montpellier, Ctr Reg Pharmacovigilance, Serv Pharmacol Medicale & Toxicol, Montpellier, France
[3] CHU Bordeaux, Ctr Reg Pharmacovigilance, Serv Pharmacol Medicale, Pole Sante Publ, Bordeaux, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2023年 / 37卷
关键词：
immune checkpoint inhibitors; peripheral neuropathy; pharmacovigilance;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-043
引用
收藏
页码：117 / 118
页数：2
相关论文
共 50 条
  • [1] Peripheral neuropathies associated with immune checkpoint inhibitors
    De Clerck, Lucie
    Peuvrel, Lucie
    Wiertlewski, Sandrine
    Pereon, Yann
    Magot, Armelle
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 : S16 - S16
  • [2] Peripheral neuropathies associated with immune checkpoint inhibitors
    De Clerck, Lucie
    Balloy, Gaelle
    Peuvrel, Lucie
    Wiertlewski, Sandrine
    Pereon, Yann
    Magot, Armelle
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 (04) : 528 - 528
  • [3] PERIPHERAL NEUROPATHIES AFTER BRAF AND/OR MEK INHIBITORS TREATMENT: A PHARMACOVIGILANCE STUDY
    Picca, A.
    Birzu, C.
    Berzero, G.
    Sanchez-Pena, P.
    Gaboriau, L.
    Vidil, F.
    Lenglet, T.
    Tafani, C.
    Ricard, D.
    Psimaras, D.
    Bihan, K.
    NEURO-ONCOLOGY, 2022, 24
  • [4] Peripheral neuropathies after BRAF and/or MEK inhibitors treatment: A pharmacovigilance study
    Picca, A.
    Birzu, C.
    Berzero, G.
    Sanchez-Pena, P.
    Gaboriau, L.
    Vidil, F.
    Lenglet, T.
    Tafani, C.
    Ricard, D.
    Psimaras, D.
    Bihan, K.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 139 - 140
  • [5] Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study
    Pascale Palassin
    Alexandre T. J. Maria
    Chayma Ladhari
    Xavier Quantin
    David Montani
    Arnaud Bourdin
    Clément Boissin
    Pierre Fesler
    Dominique Hillaire-Buys
    Philippe Guilpain
    Jean-Luc Faillie
    Cancer Immunology, Immunotherapy, 2022, 71 : 3093 - 3097
  • [6] The Occurrence of Encephalitis Due to Immune Checkpoint Inhibitors: A Pharmacovigilance Study
    Yugo Chisaki
    Hiroki Hata
    Chikako Matsumura
    Yoshitaka Yano
    Therapeutic Innovation & Regulatory Science, 2022, 56 : 323 - 332
  • [7] Association of Pulmonary Sepsis and Immune Checkpoint Inhibitors: A Pharmacovigilance Study
    Xia, Shuang
    Gong, Hui
    Zhao, Yichang
    Guo, Lin
    Wang, Yikun
    Zhang, Bikui
    Sarangdhar, Mayur
    Noguchi, Yoshihiro
    Yan, Miao
    CANCERS, 2023, 15 (01)
  • [8] Pulmonary tuberculosis associated with immune checkpoint inhibitors: a pharmacovigilance study
    Zhu, Jianhong
    He, Zhichao
    Liang, Dan
    Yu, Xiaoxia
    Qiu, Kaifeng
    Wu, Junyan
    THORAX, 2022, 77 (07) : 721 - 723
  • [9] The Occurrence of Encephalitis Due to Immune Checkpoint Inhibitors: A Pharmacovigilance Study
    Chisaki, Yugo
    Hata, Hiroki
    Matsumura, Chikako
    Yano, Yoshitaka
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2022, 56 (02) : 323 - 332
  • [10] Hemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: A pharmacovigilance study
    Diaz, L.
    Dillies, A. C.
    Le Souder, C.
    Guilpain, P.
    Faillie, J. L.
    Maria, A.
    Palassin, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 149 - 149
12345